Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial

Launched by UNIVERSITY HOSPITAL, BREST · Sep 17, 2018

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Major patient
• • Pregnant of a singleton
• • Followed at Brest hospital and resident unless 30 kms of Hospital
• • Patient consultant for preterm delivery threat before 34 weeks of amenorrhea with more than 6 contractions per hour (ie 1 in 10 minutes) felt and / or sensed by external toco-ergometry associated with cervical changes objectified by a measurement of the cervix by ultrasound between 15 and 25 mm
• • With capacity of a free and informed consent
• • Affiliated member of the French social security system
• Exclusion Criteria:
• • Patient transferred for preterm delivery from a peripheral hospital center
• • Patient not followed at Brest hospital
• • Patient doesn't lives within 30 km of the Brest hospital
• • Clinical premature rupture of membranes
• • Circled patients
• • Important metrorrhagia
• • Cervix \<15 mm
• • Cervical dilatation \> 3 cm
• • Isolated short cervix defined by a short cervix in measurement of the cervix by ultrasound without uterine contraction felt or captured in external toco-ergometry
• • Placenta previa, placenta percreta
• • Multiple pregnancy
• • Suspicion of chorioamnionitis
• • Associated maternal-fetal pathology that may induce prematurity
• • No prenatal corticosteroid treatment for this pregnancy